Recent reports on benign breast biopsies state that the ALDH1 activity associated with enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2), a protein involved in SC renewal and carcinogenesis, is a prognostic marker for the risk of developing cancer [45]. The gene discussed is ALDH1A1; the disease is cancer.